New England Journal of Medicine· 2014Q1
Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis
- 2,895citations
- Q1SCImago
- 2014year
Short summary
Transcatheter aortic-valve replacement (TAVR) with a self-expanding prosthesis resulted in a significantly lower rate of death from any cause at 1 year (14.2%) compared to surgical aortic-valve replacement (19.1%) in patients with severe aortic stenosis and increased surgical risk.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine